Innovative Drug Concept Stocks Rebound on Aug 17; Yuhuan Hits Daily Limit Up
On August 17, 2026, innovative drug concept stocks on the Chinese A-share market probed lows before rebounding. Yuhuan Pharmaceutical surged to the daily limit up, while Huasen Pharmaceutical had already sealed its limit-up board. Zhijiang Bio, Shiyao Innovation, Longshen Rongfa, Tailong Pharmaceutical, WuXi AppTec, and Lifang Pharmaceutical followed with gains, as buying interest returned to the sector during the session.
On August 17, 2026, the innovative drug sector dipped to session lows before rebounding. Yuhuan Pharmaceutical hit the daily limit up, while Huasen Pharmaceutical had already sealed a limit-up board earlier in the session. Other gainers included Zhijiang Bio, Shiyao Innovation, Longshen Rongfa, Tailong Pharmaceutical, WuXi AppTec, and Lifang Pharmaceutical.